Finance

Lists
RGT:ASX
Argent BioPharma Ltd
A$0.032
0.00%
(0.00) 1D
Sep 7, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RGT...
Open
A$0.03
High
A$0.03
Low
A$0.03
Mkt. cap
3.98M
Avg. vol.
545.60K
Volume
13.82K
52-wk high
A$0.13
52-wk low
A$0.03
EPS
-A$0.13
Shares outstanding
116.61M
Open
A$0.03
High
A$0.03
Low
A$0.03
Mkt. cap
3.98M
Avg. vol.
545.60K
Volume
13.82K
52-wk high
A$0.13
52-wk low
A$0.03
EPS
-A$0.13
Shares outstanding
116.61M
About Argent BioPharma Ltd
CEORoby Zomer
Employees-
Founded2005
Headquarters-
SectorPharmaceutical industry
Websiteargentbiopharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
85.75K
85.75K
-5.16K
-5.16K
Cost of goods sold
103.51K
103.51K
-3.11K
-3.11K
Cost of revenue
103.51K
103.51K
-3.11K
-3.11K
Research and development expenses
201.15K
201.15K
43.94K
43.94K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.26M
1.26M
2.17M
2.17M
Operating expense
1.47M
1.47M
2.24M
2.24M
Total operating expenses
1.58M
1.58M
2.24M
2.24M
Operating income
-1.49M
-1.49M
-2.24M
-2.24M
Other non operating income
66.88K
66.88K
-150.19K
-150.19K
EBT including unusual items
-1.47M
-1.47M
-2.39M
-2.39M
EBT excluding unusual items
-1.44M
-1.44M
-2.39M
-2.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
13.05K
13.05K
16.93K
16.93K
Net income
-1.47M
-1.47M
-2.39M
-2.39M
Net profit margin
-1,711.52%
-1,711.52%
46,304.27%
46,304.27%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-16.75K
-16.75K
-102.00
-102.00
Net interest expenses
-16.75K
-16.75K
-102.00
-102.00
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.47M
-1.47M
-2.18M
-2.18M
Gain or loss from assets sale
-
-
12.69K
12.69K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps